-
Guangzhou and Zhuhai Unveil Measures to Stimulate Biopharmaceutical Industry Growth
•
In a bid to bolster the biopharmaceutical and health industries, the cities of Guangzhou and Zhuhai in Guangdong province have released Measures aimed at “Promoting High-Quality Development of the Biopharmaceutical Industry.” These policies are designed to refine the development environment and enhance the competitive edge of the sector. Guangzhou’s policy,…
-
Shanghai Medical Products Administration Issues Trial Measures for Pharmaceutical Quality and Safety Personnel
•
The Shanghai medical products administration has released the “Measures for the Management of Key Quality and Safety Management Personnel of Drug Production and Operation Enterprises in Shanghai (Trial)”. These measures aim to tackle current issues in managing key personnel responsible for drug quality and safety within enterprises and to bolster…
-
Autobio Diagnostics Expands Strategic Partnership with Guorun Medical Supply Chain Services
•
China-based Autobio Diagnostics Co., Ltd (SHA: 603658) has announced a strategic partnership with Guorun Medical Supply Chain Services (Shanghai) Co., Ltd, along with 11 shareholding companies. This collaboration aims to enhance the procurement and distribution of in vitro diagnostic (IVD) products and services, ensuring a robust supply chain and fostering…
